1 |
M. Singh, R. Rathi, A. Singh, J. Heller, G.P. Talwar and J.Kopecek, Controlled release of LHRH-DT from bioerodible hydrogel microspheres, Int. J. Pharm., 76, R5-R8 (1991)
DOI
ScienceOn
|
2 |
F. Kaiho, Y. Takahashi, R. Ichihara, A. Watanabe, T. Yamashitaand Y. Kato, Application of fatty alcohol to pharmaceuticaldosage form. III. Percutaneous absorption of indomethacin from fatty alcohol and propylene glycol (FAPG) bases consisting of a mixture of fatty alcohol and propylene glycol,Yakugaku Zasshi, 106(1), 47-53 (1986)
DOI
|
3 |
M.M.T. Buckley and R.N. Brogden, K-etorolac: A review ofits pharmacokinetic properties and therapeutic potential, Drugs, 39(1), 86-109 (1990)
DOI
ScienceOn
|
4 |
J.R. Gross, The evolution of absorbent materials : In Absorbent Polymer technology, L. Brannon-Peppas and R.S.Harland(Ed.), Elsevier, New York, U.S.A., PP. 3-22 (1990)
|
5 |
A.S. Hoffman, Hydrogels-A Broad Class of Biomatehals : In Polymers in Medicine and Surgery, R.L. Kronenthal, Z.Oser and E. Martin(Ed.), Plenum Press, New York, U.S.A.,pp. 34-44 (1975)
|
6 |
M.M. Welz and C.M. Ofner III, Examination of self-crosslinked gelatin as a hydrogel for controlled release, J.Pharm. Sci., 81(1), 85-90 (1992)
DOI
|
7 |
C.K. Shim and S.H Yeo, Albumin-crosslinked PVP hydrogel as a gastric retention platform, J. Kor. Pharm. Sci.,23(3), 145-153 (1993)
|
8 |
S.H. Kam, E.S. Park and S.C. Chi, Skin permeation of indomethacin from gels, J. Kor. Pharm. Sci., 25(2), 129-136 (1995)
|
9 |
R.M. Nalbandian, R.L. Henny and H.S. Wilks, Artificialskin II. Pluronic F-127 silver nitrate or silver lactate gel inthe treatment of thermal burns, J. Biomed. Mater. Res., 6, 583-590 (1972)
DOI
|
10 |
S. Miyazaki, Y. Ohkawa, M. Takeda and D. Attwood,Antitumor effect of Pluronic F-127 gel containing mitomycin C on sarcoma-180 ascites tumor in mice, Chem Pharm. Bull., 40(8), 2224-2265 (1992)
DOI
ScienceOn
|
11 |
C.M. Lehr, J.A. Bouwstra, W. Kok, A.G. de Boer, J.J. Tukker,J.C. Verhoef, D.D. Breimer and H.E. Jungmger, Effects of mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat, J. Pharm. Pharmacol,4, 402-407 (1992)
|
12 |
M.D. Vlachou, D.M. Rekkas, P.P. Dallas and N.H. Choulis,Development of and in vitro evaluation of gnseofulvin gelsusing Franz diffusion cells, Int. J. Pharm., 82, 47-52 (1992)
DOI
ScienceOn
|
13 |
K. Kakemi, T. Ahta, R. Hori and R. Konish, Absorption andexcretion of drugs XXX. Absorption of barbituric acid derivatives from rat stomach, Chem. Pharm. Bull., 15(10),1534-1539 (1967)
DOI
ScienceOn
|
14 |
P.C. Chen-Chow and S.G. Frank, In vitro release of lidocainefrom Pluronic F-127 gels, Int. J. Pharm., 8, 89-99 (1981)
DOI
ScienceOn
|
15 |
H.L. Lueen, J.C. verhoef, G. Borchard, C.M. Lehr, A.G. de Boer and H.E. Junginger, Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil arepotent inhibitors of the intestinal proteolytic enzyme trypsin, Pharm. Res., 12(9), 1293-1298 (1995)
DOI
ScienceOn
|